Amgen’s Imdelltra combo cuts risk of death by 58% in lung cancer
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama…
Moderna, Merck’s cancer vaccine data a major advancement
Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck‘s latest data on their…
Moderna stock falls after cancer vaccine data leak
Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely…
Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial
Eli Lilly on Wednesday said its experimental combination regimen showed greater weight loss than a high dose of…
Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a…
Trump strikes new drug pricing deals with nine midsized drugmakers
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…
CNBC Daily Open: Watching Iran’s economy; a losing game for bonds
Treasury Secretary Scott Bessent speaking to CNBC on May 14th, 2026 from Beijing, China. CNBC Hello, this is…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
Hantavirus cases spark surge in pharma, biotech stocks — here’s why
ILLUSTRATION of hantavirus testing concept with laboratory tubes containing cotton swabs and HANTAVIRUS labels photographed in front of…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7B
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…